Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Paclitaxel-based chemoradiotherapy and selective surgery for esophageal cancer
NCT00069953Phase 2Completed
- Sponsor
- NRG Oncology
- Start
- Sep 2003
- Primary completion
- Mar 2007
- Modality
- Cytokines & Interferons, Fc-Fusion Proteins
- Countries
- 1
01
Overview
A Phase 2 trial of Paclitaxel Micelles for Injection in esophageal cancer, sponsored by NRG Oncology. Started Sep 2003; status: completed.
02
Drugs
Paclitaxel Micelles for Injection
03
Conditions
esophageal cancer
Beyond the preview
Go deeper on NCT00069953.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00069953.